MG
AMED

Mather Group’s Amedisys AMED Stock Holding History

Mather Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18
Closed -$1.67K – 652
2025
Q1 		$1.67K Hold
18
– – ﹤0.01% 1593
2024
Q4 		$1.63K Hold
18
– – ﹤0.01% 1561
2024
Q3 		$1.74K Hold
18
– – ﹤0.01% 1502
2024
Q2 		$1.66K Buy
18
+2
+13% +$186 ﹤0.01% 1935
2024
Q1 		$1.52K Buy
+16
New +$1.5K ﹤0.01% 1580

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Mather Group's AMED Position: Q2 2025 in Review

Mather Group sold out of Amedisys (AMED) in Q2 2025, closing a stake of 18 shares — an estimated $1.67K sold.

Mather Group first reported a position in AMED in Q1 2024 and held it in 5 quarters. The position peaked at $1.74K in Q3 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Mather Group reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Mather Group sold 18 Amedisys shares in Q2 2025, an estimated $1.67K.
  • Mather Group first reported a position in Amedisys in Q1 2024 and held it in 5 quarters.
  • Mather Group's Amedisys position peaked at $1.74K in Q3 2024.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Mather Group's 13F filing for Q2 2025, filed 15 Jul 2025.